Biohaven Pharmaceutical (NYSE:BHVN) reported quarterly losses of $(1.75) per share. This is a 8.38 percent increase over losses of $(1.91) per share from the same period last year.
Related Posts
Amazon Bedrock Challenges Google and Microsoft: Thousands Flock to Test its Cutting-Edge AI Service
Amazon.Com, Inc (NASDAQ: AMZN) cloud division has attracted thousands of customers to try out its service vying with Microsoft Corp (NASDAQ: MSFT) and Alphabet Inc (NASDAQ:
Colony Bankcorp’s Earnings Outlook
Colony Bankcorp (NASDAQ:CBAN) is set to give its latest quarterly earnings report on Wednesday, 2023-07-26. Here’s what investors…
Oracle Introduces New AI Capabilities Within Oracle Fusion Cloud Customer Experience (CX) To Help Marketers, Sellers, And Service Agents Accelerate Deal Cycles
New AI capabilities in Oracle Cloud CX help marketers, sellers, and service agents, improve customer satisfaction, increase productivity, and accelerate deal cyclesMEXICO CITY, April 25, 2024 /PRNewswire/ --